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MHC class II, antigen presentation and tumor necrosis factor in renal
tubular epithelial cells. Proximal tubular (PT) epithelial cells express
MHC class II (La) antigens in immunologically-mediated renal injury.
To study the role of PT as accessory cells, we generated several murine
PT-like epithelial cell lines by transformation with origin-defective
SV4O DNA. These transformed cell lines display typical alkaline
phosphatase and y-glutamyl-transpeptidase enzyme activity, prolifera-
tion to epidermal growth factor (EGF) and sodium-dependent glucose
uptake. Clonal lines of transformed tubular cells from both normal
C3H/FeJ and autoimmune MRL-lpr mice do not constitutively express
Ia antigens or mRNA for class II. However, stimulation with recombi-
nant interferon-7 (rIFN-7) induces Ia mRNA and surface product in the
cell lines. These Ia-positive cells can process and present hen egg-white
lysozyme (HEL) to antigen-specific Ia"-restricted T cell hybrids. Un-
stimulated tubular cells do not express detectable IL-la, LL-ll, TNF-a,
or IL-6 mRNA. However, stimulation with IL-I a or LPS induces
TNF-a transcripts. We conclude that these cell lines have characteris-
tics most consistent with a proximal tubular origin. They also bear
characteristics of accessory cells such as processing and presentation of
antigen and TNF-a gene expression. We speculate that PT have the
capacity to participate in the pathogenesis of immune renal injury.
Proximal tubular (PT)' epithelial cells in the kidney express
major histocompatibility (MHC) class II (Ia) antigens in various
inflammatory conditions, such as allograft rejection [1], graft-
versus-host disease [2], and lupus nephritis [3]. We have
previously shown that the PT of autoimmune MRL-lpr mice
display focal Ia expression by two months of age, preceding
glomerulonephritis [4]. Early focal PT Ia expression could be an
important mechanism in the initiation of autoimmune renal
injury.
In cells of the immune system, Ia antigens play a fundamental
role in the presentation of foreign or autoantigens to helper T
cells. Some cells of non-hematopoietic lineage can also express
'Abbreviations used in this paper: PT, proximal tubules; SV4O,
simian virus 40; MHC, major histocompatibility complex; MRL/MpJ-
lpr/lpr, MRL-lpr; HEL, hen egg-white lysozyme; APC, antigen present-
ing cell.
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Ia antigens and function as accessory cells. Chondrocytes [5]
and enterocytes [6] for example can process and present antigen
to T cells. Other non-hematopoietic cells such as keratinocytes
[7] and pancreatic 13-cells [8] induce antigen-specific unrespon-
siveness in T cells. Thus, many non-immunologic cells which
express Ia antigens can interact with cells of the immune
system.
To define the role of renal tubular epithelial MHC class II
expression in renal injury, we generated PT-like epithelial cell
lines from renal cortical tubular cells by transformation with
origin-defective SV4O DNA. We show that clonal lines of
transformed epithelial cells retain their role as solute transport-
ing epithelium and have differentiated characteristics of acces-
sory cells, such as processing and presentation of antigen.
Moreover they have the capacity to express TNF-a transcripts.
We extrapolate that these "immune" functions may allow the
PT to participate in the pathogenesis of immune renal injury in
vivo.
Methods
Materials
Tissue culture media and reagents were from Gibco (Grand
Island, New York, USA), and chemicals from Sigma (St. Louis,
Missouri, USA). Monoclonal antibodies (MAb) for IAk (clones
10-2.16 and l4-4-4S, American Type Culture Collection
[ATCC], Rockville, Maryland, USA) and IAd (clone MK-D6)
were obtained by affinity purification of supernatants over
protein A-Sepharose CL-4B columns (Pharmacia, Piscataway,
New Jersey, USA). The rat anti-murine IFN-y MAb R4-6A2
(ATCC) was purified over recombinant protein G-Sepharose 4B
(Zymed, South San Francisco, California, USA). MAbs for
cytokeratin (PKK1) and vimentin were purchased from Lab-
systems (Helsinki, Finland). A MAb for the large T antigen of
SV4O (419) was provided by Dr. David Livingston (Harvard
Medical School). Supernatants from JSS8L cells transfected
with the munne IL-4 gene (Dr. Robert Tepper, Harvard Med-
ical School) were used as source for rIL-4. The origin-defective
SV4O mutant 6-1 has been described [9, 10]. This mutated SV4O
DNA lacks six base pairs at the SV4O origin of DNA replica-
tion, preventing viral self-replication. The source and nature of
the genomic probe for A, [11] and the cDNAs for IL-la [12],
IL-l/3 [13] and TNF-a [14] have been described elsewhere [4,
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15, 16]. A murine IL-6 cDNA clone sharing extensive sequence
homology with the published sequence [17] was obtained from
Genetics Institute (Cambridge, Massachusetts, USA). An 800
bp PstI fragment was used for hybridization.
Generation of SV4O transformed tubular epithelial cell lines
Single cortical tubular cell suspensions of freshly dissected
kidney cortices from normal two-month-old C3H/FeJ (H2k)
and from two- or five-month-old autoimmune MRL-lpr (H2k)
were prepared by collagenase dispersion (cls II, 10 mg/mI;
Worthington, Freehold, New Jersey, USA), sequential sieving
through steel meshes (250 m, 150 m, 75 m, and 38 sm), and
washing in Hanks' balanced salt solution (HBSS). Cells were
grown to subconfluence on collagen-coated 50 mm plates for six
days in modified K1 media (1:1 mixture of Dulbecco's modified
Eagle's medium [DMEM] and Ham's F12, containing the
following additives: 25 mvi Hepes, 100 U/mI penicillin, 100
pg/ml streptomycin, 5% fetal calf serum [FCS], 5 g/ml insulin,
5 g/ml transferrin, 1 ng/ml prostaglandin E1, 5 x 10 M
triiodothyronine, 108 M sodium selenite, 5 x 10 M hydro-
cortisone, 25 ng/ml epidermal growth factor; EGF). Cells in
primary culture displayed strong alkaline phosphatase reactiv-
ity, a brush border marker enzyme of PT. Using the calcium-
phosphate co-precipitation method [18], the cells were trans-
fected with origin-defective SV4O DNA mutant 6-1 in pMKl6
(20 g per 50 mm culture dish) and maintained with weekly
changes of fresh modified K! media. Distinct foci of outgrowing
cells became apparent after six weeks. These foci of clonal cells
were transferred to 24-well plates and were then passaged by
trypsinization (trypsin 0.5 .tg/ml and EDTA 0.53 mM). PT cell
lines from C3H/FeJ mice were designated Cl, and those from
MRL-lpr mice, Ml and M3. Cells were subcloned in 96-well
plates by the limiting dilution technique to exclude the possi-
bility of a mixed cell population. Briefly, using an irradiated
(3000 rads) feeder layer of the same cell type, cells were plated
out in 96-well plates at 0.3, 1 and 10 cells/well. Positive wells
from the lowest dilution with less than 10% positive wells were
selected. The subclones retained alkaline phosphatase activity
and were designated C1.1, M1.l and M3.1.
Enzyme cytochemistry
Confluent monolayers of SV4O transformed cells were as-
sessed for brush border enzyme activity. Alkaline phosphatase
activity was demonstrated by incubating unfixed cells for 60
minutes with an alkaline solution of naphthol AS-MX phos-
phate containing Fast Blue RR salt (Sigma, kit # 85). y-
glutamyl-transpeptidase activity was visualized according to
Rutenburg et al [19] by incubating the unfixed cells for 60
minutes in a solution containing 0.125 mg/mI y-glutamyl-4-
methoxy-fl-naphthylamide, 0.5 mg/mI glycylglycine, and 0.5
mg/ml Fast Blue BBN, followed by postcoupling with 100 mM
copper sulfate. Reactions were scored positive or negative.
Immunofluorescence
Transformed cells were grown on glass coverslips to conflu-
ence and fixed for two minutes with 2% paraformaldehyde. The
cells were then washed twice with 50 ms'i Tris buffer (pH 7.6),
incubated with diluted (1:10) MAb for cytokeratin, vimentin or
large T antigen, washed twice with 50 mri Tris buffer, and then
incubated with fluorescein-conjugated affinity-purified goat an-
ti-mouse IgG (F(ab')2 fragment (Cappel, Cochranville, Pennsyl-
vania, USA). After two washes with Tris buffer, the coverslips
were mounted with glycerol-gelatin and examined by fluores-
cence microscopy.
Proliferation assays
Growth characteristics of SV4O transformed cells in response
to EGF were studied by [3H]thymidine incorporation and also
using a colorimetric assay [20]. For both assays, cells (5 x LO
or iO cells/well) were placed in collagen-coated 96-well plates
and grown in DMEM/Ham's Fl 2 (1:1) with or without EGF (25
nglml), containing 25 mM Hepes, penicillin (100 U/ml) and
streptomycin (100 jxglml). After 24 hours the cells were then
pulsed with [3H]thymidine (1 pCi/well) overnight and harvested
using a PHD cell harvester (Cambridge Technology, Cam-
bridge, Massachusetts, USA). For the colorimetric assay,
which directly reflects the number of metabolically active cells
in the wells, cells were grown in 96-well plates for 48 hours,
followed by a four hour pulse with 50 pg of 3-[4,5-dimethyl-
thiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT). Living
cells cleave the tetrazoliuim ring from MTT, producing a blue
formazan salt. An equal volume of 10% sodium dodecyl sulfate
(SDS) was added for 12 hours to dissolve the insoluble for-
mazan. The plates were read at 570 nm on a Dynatech mi-
croELISA reader, subtracting the OD at 650 nm as background.
PGE2 synthesis
Transformed cells were grown to confluence for two to four
days. The media was changed for 24 hours to media without
additives. One hour before stimulation the media was changed
once. The cells were then stimulated with angiotensin II (Ang
II), arginine-vasopressin (AVP) or calcium-ionophore A23 187
for 30 minutes. The supernatant was immediately assayed for
PGE2 using a direct competitive radloimmunoassay as previ-
ously described [21].
Cyclic AMP generation
SV4O transformed cells were grown as described above for
PGE2 synthesis. The cells were stimulated for 30 minutes with
parathyroid hormone (PTH), AVP or forskolin. The superna-
tants were collected and assayed for extracellular cAMP using
a commercially available kit (Amersham, Arlington Heights,
Illinois, USA).
Sodium-glucose cotransport
Sodium-dependent glucose uptake was studied according to
Stanton et al [22], using methyl a-D-glucopyranoside ['4C]
(New England Nuclear, Boston, Massachusetts, USA), a non-
metabolizable analogue of D-glucose. Transformed cells were
grown in 6-well plates for two or three days until confluent. The
cells were then washed three times with a sodium-containing
solution (135 mri Na, 4 mti K, 1 mM Mg2, 1.8 ms Ca2, 5
mM Hepes, 5 mM L-alanine, 1.5 mrvi P043, 0.5 m methyl
a-D-gluco-pyranoside), or a solution where the sodium was
replaced by N-methyl-D-glucamine, or a sodium-containing
solution containing 0.5 mri phloridzin. The cells were then
incubated at 37°C for 15 or 60 minutes with 1.5 ml of the
corresponding solutions containing 0.6 pCi methyl a-D-glu-
copyranoside ['4C]. The uptake was terminated by rinsing the
wells three times with ice-cold stop solution (156 msi MgSO4, 1
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mM Tris, 1.6 mtt Hepes, pH 7.6). The cells were permeabilized
with 0.1 N NaOH for one hour, and the solution neutralized
with 1 N HC1. The uptake in the solutions was counted by liquid
scintillation spectroscopy. The total protein content in the
solutions was determined by the Coomassie Blue dye binding
method (Biorad, Richmond, California, USA).
RNA preparation
Total RNA was isolated from confluent monolayers of trans-
formed cells using a single-step acid guanidinium isothiocy-
anate-phenol-chloroform extraction method [231. The cells
were lysed with a denaturing solution of 4 M guanidinium
isothiocyanate (BRL, Gaithersburg, Maryland), 25 m sodium
citrate, 0.5% sarcosyl, and 0.1 M 2-mercaptoethanol, and the
lysate was directly extracted with phenol and chloroform. After
isopropanol precipitation and 75% ethanol washes, the RNA
was quantitated by measuring the OD at 260 nm.
Northern analysis
Total RNA (25 pjg) was denatured with 1 M glyoxal and 50%
dimethylsulfoxide, electrophoresed through a 1.5% agarose gel,
and transferred onto Gene Screen nylon membranes (New
England Nuclear, Boston, Massachusetts, USA). The RNA
was baked onto the membrane at 80°C for four hours, and blots
were prehybndized with 25 g/ml denatured salmon sperm
DNA and 25 g/ml yeast tRNA in 50% formamide, 0.04%
polyvinylpyrrolidone, 0.04% bovine serum albumin, 0.04%
Ficoll, Sx standard sodium citrate (SSC) and 1% SDS. Probes
were radiolabeled by primer extension using random hexanu-
cleotides [24]. Blots were hybridized for 16 to 24 hours at 42°C
and washed under stringent conditions (twice at room temper-
ature with 2xSSC, 1% SDS; twice at 65°C with 2xSSC, 1% SDS;
and twice at 65°C with 0.1xSSC, 1% SDS). Following hybrid-
ization the blots were exposed to Kodak X-AR film. All blots
were also rehybridized with /3-actin to ensure that equal
amounts of RNA were loaded for electrophoresis.
Flow cytometry
SV4O transformed cells were trypsinized, washed with
HBSS, and stained for MHC class II antigens using MAbs
10-2.16 (anti I-A'), l4-4-4S (anti I-E'), or irrelevant MAb
MK-D6 (I-A") as primary antibody. Fluorescein-conjugated
affinity-purified goat anti-mouse IgG F(ab')2 fragment was used
as secondary step. Cells were analyzed with a Becton-Dick-
inson flow cytometer.
Antigen presentation
Transformed tubular epithelial cells were cultured for three
days in the presence or absence of rIFN-y (100 U/mI) for Ia
induction. Antigen-presentation was then determined by using
two previously-described T cell hybrids [25], which are Iak
restricted and specific for hen egg-white lysozyme (T hybrid
ClO, and a subclone of A2.2B2, the A2A2 hybrid). Such hybrids
secrete interleukin-2 (IL-2) when co-cultured with Ia-matched
antigen presenting cells (APC) in the presence of the appropri-
ate foreign antigen. Varying numbers (3 x i0 to 10) of
Ia-positive PT or control B cells (TA3 and 2B 1 B cell hybrid-
omas) were co-cultured with l0 T hybrid cells in 96-well plates
with 50 jsg/well of hen egg lysozyme (HEL, Sigma). After 24
hours, supernatants were collected and assayed for IL-2 con-
tent in a secondary culture using HT-2 cells, an IL-2 dependent
T cell line. HT-2 cells (5 x jo3) were cultured for 24 hours in the
presence of serial dilutions of the primary culture supernatant.
The degree of stimulation was determined visually (in arbitrary
U/mI of IL-2) according to Kappeler et al [26] or by the
incorporation of [3H]thymidine into DNA six hours later. To
study antigen processing, cells were pulsed with HEL and fixed
with 1% paraformaldehyde (10 mm at room temperature), or
fixed and then exposed to HEL before culturing with the T cell
hybrids.
Cytokine production
Transformed tubular epithelial cells were grown to conflu-
ence and stimulated for 24 hours with rIL- 1 a, rTNF-a, lipo-
polysaccharide (LPS; S. minnesota, Calbiochem, La Jolla,
California, USA), rIL-4 or rIFN-y. RNA was extracted, elec-
trophoresed and blotted as described. Blots were hybridized as
described above with specific eDNA probes for the generation
of IL-la, IL-lp, TNF-a, or IL-6 mRNA.
Results
Morphologic characterization of the transformed cell lines
Transformation of primary cortical tubular cell cultures with
origin-defective SV4O DNA resulted in successful generation of
uniform clonal cell lines with characteristics of PT (Fig. 1 and
Table 1). Transformed tubular epithelial cell lines from C3H/
FeJ (Cl) and MRL-lpr (Ml, M3) all form rapidly growing
adherent monolayers. In addition, dome formation is detected,
indicating a functional transporting epithelium. Positive nuclear
staining for the SV4O large T antigen is detected in all cells,
indicating transformation by SV4O DNA, and excluding the
presence of untransformed cells. All cell lines display histo-
chemical reactivity for alkaline phosphatase and y.glutamyl-
transpeptidase, two brush border marker enzymes, and stain by
immunofluorescence uniformly with intracytoplasmic cytoker-
atm, an epithelial cell marker, but not with vimentin, a mesen-
chymal marker. No macrophages are detected.
Growth characteristics
Cell growth was studied to determine whether growth factors
such as EGF retain their ability to regulate proliferation. By
phase microscopy the two cell lines examined (C 1.1 and M3.l)
proliferate more rapidly in the presence of EGF (25 ng/ml) than
with control media (DMEM/Fl2 1:1) alone. As shown in Fig-
ure 2 (upper panel), both cell lines demonstrate enhanced [3H]
thymidine incorporation (1- to 3-fold in various experiments) in
response to EGF, indicating DNA synthesis. M3. 1 cells prolif-
erate more slowly than Cl. I cells. These results were confirmed
in a second assay for cell proliferation, MTT cleavage as
determined by colorimetry (Fig. 2, lower panel). This assay
directly reflects the number of metabolically active cells in the
wells. Addition of either EGF, hormone mixture (insulin,
transferrin, sodium selenite, hydrocortisone, PGEI and triiodo-
thyronine) or 5% FCS to the control media results in enhanced
cell growth. Combination of all three additives (EGF, hormone
mixture and FCS modified K!) results in the highest prolifer-
ation rate.
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Fig. 1. Phase micrograph of SV4O transformed tubular epithelial cells derived from MRL-lpr (M3.I), demonstrating homogeneous confluent
mono/ayers (x200).
Table 1. Morphologic characterization of SV4
epithelial cell lines
0 transformed tubular
Cell type Cl. I MI .1 M3.1
Histochemistry
alkaline phosphatase ÷
y-glutamyl-transpeptidase +
Immunocytochemistry
SV4O large T antigen +
cytokeratin +
vimentin —
+
+
+
+
—
+
+
+
+
—
Transformed cells were grown to confluence in 50 mm culture dishes
for enzyme cytochemistry, and on glass coverslips for immunofluores-
cence. Key: —, negative; +, positive.
Functional characterization
PGE2 synthesis and cAMP production. Transformed cells
(Cl) were studied for hormonal responsiveness (Table 2). Ang
11(10—8 to 106 M) induces a dose-dependent increase in PGE2
synthesis, whereas AVP (106M) does not stimulate PGE2
synthesis. Ang Il-stimulated PGE2 synthesis is blocked with
indomethacin. Calcium-ionophore A23 187 also induces PGE2
synthesis. PTH weakly stimulates cAMP production. A stron-
ger cAMP response is seen to AVP, suggesting that these
tubular cells, unlike untransformed PT, have vasopressin re-
ceptors. Subcloned Cl. 1 also produce cAMP in response to
both PTH and AVP (not shown), suggesting that the AVP
response is not due to a contaminated distal cell type. Forsko-
lin, a direct stimulator of adenylate cyclase also enhances
cAMP synthesis in Cl.! (45 mm stimulation: control, 1.1 0.2
pmol/well; forskolin i0 M, 48.0 0.0 pmollwell, P < 0.001).
Sodium-dependent D-hexose uptake. Cl.l and M3.l cells
were examined for sodium-glucose cotransport, a specific func-
tion of PT. Figure 3A shows one representative experiment of
four in C1.l cells. Both cell lines show uptake of the non-
metabolizable analogue of D-glucose, methyl a-D-glucopyra-
noside ['4C]. Uptake is apparent at 15 minutes, and further
increased at 60 minutes. Uptakes were lower than what has
been reported in the literature for untransformed cells [22, 32].
The transport is inhibited by 0.5 mrvi phloridzine, a specific
inhibitor of the sodium-glucose co-transporter. Uptake is also
inhibited in sodium-free solution where the NaC1 is replaced by
N-methyl-D-glucamine. Figure 3B summarizes the inhibitory
effect of phloridzine and sodium removal in Cl.! and M3.l cells
in three separate experiments.
Regulation of MHC class II expression
Unstimulated cells (Cl, Ml and M3) do not display surface Ia
or mRNA for class II, but can be induced to express Ia when
stimulated with rIFN-y (10 to 1000 U/ml for 3 days). Figure 4
(left panel) shows flow cytometric analyses of rIFN-y stimu-
lated Cl, Ml and M3 cells. Both I-A (MAb 10-2.16) and I-E
(MAb 14-4-4S, not shown) expression is induced with rIFN-yin
all three cell lines. No class 11-specific mRNA is detected in
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Table 2. PGE2 and cAMP synthesis by SV4O transformed tubular
cells
PGE2
Sample pg/well
Experiment 1
control 6.5 6.5
Ang II iO M 0.0 0.0
Ang II iO M 144.5 374a
Ang 1110—6 M 289.5 19.7a
AVP 10_6 M 0.0 0.0
Ang II 106 M + indomethacin (10—n M) 0.0 0.0
Experiment 2
control 41.5 3.2
A23187 l0— M 192.5 14.6a
Sample
cAMP
fmol/well
Experiment 3
control 243 11
PTH 10—10 M 304 24
PTH j—9 M 376 26
AVP i0 M > 1024
Transformed tubular cells (Cl) were grown for 2 to 3 days in
24-well plates, washed once, and stimulated for 30 mi PGE2 and
extracellular cAMP (N = 4) were assayed in duplicates by radioimmu-
noassay as described in Methods. Results are mean SE.
a p < 0.05 when compared with respective controls (t-test).
Antigen presentation studies
Fig. 2. Proliferation assay of transformed tubular cells (Cl .1 and
M3.l). Cells were placed in 96-well plates (, C1.1, 5 x 103/well; PA,
M3. 1, l04/well). A. [3H]thymidine incorporation over 18 hr in Cl.! and
M3. 1 cells, grown for 24 hr in DMEM/F12 media (1:1) with or without
EGF (25 ng/ml). B. MTT cleavage over 4 hr by Cl.! and M3.l cells,
grown for 48 hr in DMEM/F12 with either EGF (25 ng/ml), hormone
mixture (insulin, triiodothyronine, PGE1, hydrocortisone, sodium se-
lenite and transferrin), FCS (5%), or in modified Kl media. Results are
mean SE from quadruplicate determinations. * P < 0.05 (t-test).
unstimulated cells by Northern analysis (Fig. 4, right panel), but
Ia transcripts can be induced with rIFN-y.
Recombinant IFN-y stimulated class II expression was fur-
ther studied in Cl cells. The IFN-y induced Ia expression is
blocked with anti-murine IFN-y MAb R4-6A2 (Fig. 5, lanes ito
4). Cycloheximide (0.5 to 5 xgIml) also blocks IFN-y stimulated
Ia induction (Fig. 5, lanes 5 to 8), suggesting that protein
synthesis is necessary for this induction. In addition, rIFN-y
stimulated Ia expression can also be inhibited by l0— M
dexamethasone and hydrocortisone (Fig. 5, lanes 9 and 10).
Hydrocortisone at a lower dose (5 x lQ— M) inhibited the
response partially (not shown).
The cell lines were stimulated with the other known Ia-
inducing cytokines TNF-a and IL-4 (Fig. 6). Recombinant
TNF-a (100 ng/ml) and rIL-4 (1000 U/ml) do not induce detect-
able Ia mRNA levels in Cl cells. Combining rTNF-a(lOO ng/ml)
Since one function of Ia molecules is to participate in antigen
presentation to T cells of the CD4 phenotype, we sought to
determine whether tubular epithelial cells have antigen present-
ing capacity. Cl, Ml and M3 cells were examined for their
ability to present antigen to HEL-specific, Iakrestricted T cell
hybrids (Table 3). Class II negative tubular cells do not activate
Iakrestricted ClO cells in the presence of HEL, whereas
rIFN-y induced Ia-positive tubular cells do activate ClO cells.
In the absence of HEL, ClO cells are not activated by Ia
positive APC. In three other experiments, IFN-y induced Cl
and M3.l cells (3 x iO to 10) were assayed for antigen
presentation to another Ia"-restricted, HEL-specific T cell
hybrid (A2A2). Again, this hybrid releases IL-2 when co-
cultured with Ia positive Cl or M3.l and HEL, as measured in
the HT-2 assay, indicating antigen presentation (data not
shown). To determine whether tubular cells process the HEL,
Ia-positive Cl and M3. 1 cells were fixed with 1% paraformal-
dehyde after overnight exposure to HEL (Table 4). Fixed cells
retain their ability to present JTIEL to the A2A2 T hybrid.
Higher doses of fixed APC are required to obtain equal activa-
tion of A2A2 cells. Fixation of the cells prior to exposure to
HEL abolishes activation of A2A2. This indicates that the
tubular cells process the HEL prior to presentation in a fashion
similar to classic antigen presenting cells of hematopoietic
lineage (that is, macrophages and B cells).
Cytokine gene expression
Since PT share Ia expression and antigen presentation with
cells of the immune system, we sought to determine whether
these SV4O transformed tubular cells have other accessory
A
E
C)
0
Ca
Ca0N
CC)
0
and rIFN-y (10 and 50 UIml) does not potentiate Ia mRNA
induction. LPS (1 to 5 g/ml) does not affect Ia transcription.
o
 
0 
0 
0 
0 
0 
M
 
c.
' 
a
 
0 
0 
0 
0 
o
 
a
. 
Zn
 
Zn
w
 
a
 
o
 
o
 
a
 
I 
0 
0 
0 
0 
I 
I 
I 
I 
0 
0 
0 
0 
0 
O
M
EM
IF
12
 
p 
I 
_
_
_
_
_
_
_
 
C 
EG
F 
_
_
_
_
_
_
_
_
_
_
_
 
rn
 
P 
_
_
_
_
_
_
_
_
_
_
_
 
—
I 
•
 
H
or
m
M
ix
 
H
 
I 
+
 
FC
S(
5%
) 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
—
 
n
io
di
fie
d 
Ki
 
'I 
II 
788 Wuthrich et al: ía and TNF expression in epithelial cells
C
a,
a
a.
a>
E
0
E
a.
0C
a)0
>1)
CO
a)
functions, such as cytokine production. The cells (Cl and C 1.1)
were stimulated with rIL-la, TNF-a, LPS, rIL-4 or rIFN-y and
RNA was extracted for Northern analysis. Blots were probed
for IL-la, IL-f3, TNF-a or IL-6. Table 5 summarizes the
results. No steady-state mRNA levels for IL-la, IL-1f3, TNF-a,
and IL-6 are detected in total RNA obtained from unstimulated
cells. Upon stimulation with rIFN-y, rTNF-a, or rIL-4, tran-
scripts for none of the above cytokines are detected. However,
upon stimulation with rIL-la, transcripts for TNF-a are now
present (Fig. 7). Two different sources of murine rIL-la (Hoff-
mann-La Roche and Pfizer) gave similar TNF-a mRNA induc-
tion. These cells also express TNF-a when stimulated with LPS
(1 gIml). TNF-a mRNA is apparent within 24 hours.
Discussion
Renal allograft rejection [1], graft-versus-host disease [21 and
lupus nephritis [3, 41 induce MHC class II expression in the
proximal tubular epithelium of the kidney. To study the expres-
sion, regulation and function of murine Ia antigens on PT, we
have established SV4O transformed clonal PT-like epithelial cell
lines from normal and autoimmune MRL-lpr mice. These cell
lines retain many differentiated PT cell functions, and also
display differentiated accessory cell functions such as process-
ing and presentation of antigen. No inherent difference in these
accessory functions could be detected between C3H/FeJ and
autoimmune MRL-/pr derived PT. Transformation with origin-
defective SV4O DNA immortalizes cells in a differentiated state,
providing large numbers of homogeneous clonal cells for anal-
ysis. SV4O DNA has been used to generate transformed fibro-
blasts [27], macrophages [28], thymic epithelial cells [29] and
also recently a PT cell line [301. A similar approach has used the
ras oncogene to transform PT [31].
Characterization of our cell lines revealed that they have
many physiological functions typical of normal proximal tubu-
lar epithelium: brush border enzymatic activity, growth in
response to EGF, hormonal responsiveness to Ang II and PTH,
and sodium-dependent glucose uptake. Of these, Na-depen-
dent glucose uptake is a highly specific property [22, 32], since
FACS analysis Northern analysis
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Fig. 4. MHC class II expression by flow cytometry and Northern
analysis in rIFN--y stimulated tubular cells. Flow cytometry (left
panels): Cl, Ml and M3 cells were stimulated with rIFN-y (100 U/ml)
for 72 hr and stained with MAb 10-2.16. The control represents IFN-y
stimulated cells stained with secondary step reagent only. Staining with
irrelevant MAb was superimposable to controls (not shown). Northern
analysis (right panels): Cells were stimulated for 24 to 48 hr with
rIFN-y. Blots were hybridized with an Au-specific Ia probe (A), and
also rehybridized with J3-actin (B). Lane 1, unstimulated cells; lane 2,
rIFN-'y stimulated cells (Cl, 500 U/mI; Ml, 1000 U/mI; M3, 100 U/mI).
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Fig. 3. Sodium-dependent glucose transport by transformed tubular
cells (C1.1 and M3.1). Cells were grown in 6-well plates to confluence
and assayed for uptake of methyl a-D-glucopyranoside ['4C] after 15
and 60 mm. A. Uptake by Cl.! cells in sodium-containing solution (Na
sol) with or without 0,5 mti phloridzine or in sodium-free solution
(N-methyl-D-glucamine, N-M-D-Gl). Results are expressed as pmollmg
protein (duplicate determinations from a representative experiment). B.
Inhibitory effect of 0.5 mri phloridzine or replacement of sodium with
N-M-D-G1 in Cl.l (D) and M3.1 (), at 60 mm. Results are expressed
as the mean percentage of control SE. Data are pooled from 3 separate
experiments from which Fig. 3A is an example.
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Fig. 5. Blocking ofrIFN-y stimulated I-An gene
expression by anti-murine IFN-y MAb R4-6A2,
cycloheximide, dexamethasone, or hydrocortisone
(Northern analysis). Cells (Cl) were grown to
confluence for 48 hr, and stimulated with rIFN-y in
the presence of inhibitors for 24 hr. Lane 1 and 5,
control (no rIFN-y); lane 2, rIFN-y (100 UIml); lane
3 and 4, rIFN-y ÷ R4-6A2 (0.5 and 5 gIml,
respectively); lane 6, rLFN-y (1000 U/ml); lane 7,
rIFN-y + cycloheximide (0.5 g/ml); lane 8,
cycloheximide (0.5 g/ml); lane 9, rIFN-y +
hydrocortisone (10—i M); lane 10, rIFN-y +
dexamethasone (10 M).
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Fig. 6. Tubular epithelial cells (Cl) express Ia in response to rIFN--y,
but not rTNF-a, rIL-4, and LPS (Northern analysis). Lane 1, unstim-
ulated cells; lane 2, rIFN-y(lO U/mI); lane 3, rTNF-s (100 ng/ml); lane
4, rIFN-y (10 U/mI) + rTNF-a (100 ng/ml); lane 5, rIL-4 (1000 U/mI);
lane 6, LPS (1 g/m1).
it is not found on other epithelial cells in the kidney. In addition,
the transformed cell lines show enhanced proliferation to EGF,
a known growth factor of proximal tubules [33, 34]. This, is in
agreement with the detection of EGF receptors on transformed
PT reported by two other groups [30, 31]. Furthermore, our cell
lines display an appropriate response to Ang II (PGE2 synthe-
sis) and to PTH (cAMP synthesis). Unexpectedly, these cells
also generate cAMP in response to AVP, a characteristic of
distal or collecting duct epithelium. A cAMP response to AVP
was present in subcloned cells, making it unlikely that this is the
result of a contaminating distal cell type. The presence of AVP
receptors is not without precedent since the proximal tubular-
like pig epithelial cell line LLC-PK1 also produces cAMP in
response to AVP [35, 36]. Gene derepression by cellular trans-
formation may account for the expression of some distal tubular
epithelial functions by these lines. Taken together, the charac-
terization of these cell lines indicates that we have generated
PT-like cell lines with many differentiated functions of normal
PT epithelium, providing an excellent model system.
The generation of these cell lines allowed us to study the
regulation and function of tubular epithelial Ia expression. The
cell lines do not constitutively express MHC class II antigens.
Table 3. Ia-positive tubular epithelial cells process and present
antigen to Iakrestricted T cell hybridomas
Cell type IFN-y La cpm x l0
TA3 — + 299.4
Cl — — 0.7
Cl + + 14.4
MI — — 1.7
Ml + + 34.0
M3 — — 0.6
M3 + + 74.2
ClO cells (HEL-specific, Ia"-restricted; 1 X 10) were co-cultured in
96-well plates with varying numbers (3 x l0 to 10) of tubular epithelial
cells derived from C3H/FeJ (Cl) or MRL-/pr mice (Ml, M3), in the
presence of HEL (50 sg/well). The IL-2 content in the supernatants was
assayed in a secondary culture, using HT-2 cells. Results are expressed
as the maximum proliferative response ([3H]thymidine incorporation)
obtained in the secondary culture (generally achieved with 3 x 10'
Ia-positive cells), using serial dilutions of the supernatants in the
primary culture. Cells were checked for La positivity by flow cytometry
using MAb 10-2.16.
This is in agreement with other investigators using transformed
[301 or untransformed tubular cells [37] which have only mini-
mal levels of constitutive Ia [30, 37]. We were unable to
generate cell lines which constitutively express Ia, even from
nephritic MRL-/pr mice which have Ia-positive PT in vivo [4].
Freshly isolated PT from MRL-lpr mice in primary culture lose
Ia expression (unpublished observation). This suggests that a
factor which is responsible for maintaining Ia expression in vivo
is lost during the process of culture and/or transformation. A
similar situation occurs during culture of munne macrophages
which lose Ia expression in vitro [38].
The tubular cell lines could be readily induced to express
MHC class II antigens by IFN-y. This is in agreement with
another study that found that IFN-y induces HLA-DR expres-
sion in human renal cortical tubular cells [37]. Injection of
IFN-y is also known to induce PT Ia expression in vivo [39].
Other known Ia-inducing factors such as IL-4 and TNF did not
induce class II in our cell lines. No potentiating activity of TNF
on IFN-y induced class II expression could be detected,
whereas such an effect has been described in the macrophage-
like cell line WEHI-3 [40]. We also demonstrate, for the first
time, that IFN-y induced Ia-expression in tubular epithelium is
corticosteroid-sensitive, suggesting that a steroid-responsive
element is involved for class II expression in these cells, as in B
cells [41] and macrophages [42]. In contrast, other investigators
have not demonstrated inhibition of IFN-y induced Ia antigens
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Table 4. Processing of HEL by tubular epithelial cells
Cell type IFN-y Ia
APC treatment IL-2 (U/rn!)
APC
Fixation
HEL pre-
fixation
HEL during
co-culture l0 3 x i0
2B1 —
—
—
+
+
+
—
+
+
—
+
—
+
—
+
>160
>160
20
>160
>160
80
Ci —
+
+
+
—
+
+
+
—
-
+
+
—
-
+
—
+
+
—
+
<20
>160
80
<20
<20
>160
>160
<20
M3.l —
+
+
+
—
+
+
+
—
—
+
+
—
—
+
—
+
+
—
+
<20
>160
80
<20
<20
>160
>160
<20
Varying numbers of rIFN-y stimulated tubular or control 2B1 cells (3 x io to iO antigen presenting cells, APC) were co-cultured with io
HEL-specific Ia"-restricted A2A2 cells for 24 hours. HEL (50 g/we11) was added to all wells except those that had been pulsed with HEL overnight
prior to fixation with 1% paraformaldehyde (PF). Supernatants were assayed for IL-2 content in the HT-2 assay. Results are expressed in arbitrary
U/mI of IL-2 [26]. Two doses of APC are shown (10 and 3 x l0 APC). Ia expression was determined by flow cytometry.
Table 5. Cytokine profile of SV4O transformed tubular epithelial cells
Stimuli Dose
Cytokine mRNA
IL-la IL-lJ3 TNF-a IL-6
None — — — — —
rIL-la
rTNF-a
LPS
rIL-4
0.1—I sg/ml
100 ng/ml
1-Sjsglml
1000 U/ml
—
—
—
-
—
—
—
-
+
—
+
-
—
—
—
ND
rIFN-y 10-1000 U/mI — — - —
Tubular epithelial cells (Cl) were grown for 24 to 48 hours to
confluence before stimulation (24 to 48 hr) with specific cytokines. RNA
was extracted, electrophoresed and blotted as described in Methods.
Blots were probed with 32P-labeled (random priming) specific eDNA
probes, and exposed for 5 to 10 days to Kodak X-AR film. On each blot,
positive controls were included (RNA extracted from macrophage 59 or
WEHI-3 cells). ND, not done.
by corticosteroids in human cortical tubular cell cultures [37,
43]. This discrepancy might be explained by contaminating cells
or species difference [43].
The regulation of IFN-y induced Ia expression has been
studied in both immune cells of hematopoietic lineage [40, 42,
44, 45] and non-hematopoietic cell lines such as HeLa cells [46],
fibroblasts [47], glioblastoma multiforme cells [48] and osteo-
sarcoma cells [49]. However, the regulation of tubular epithelial
Ia gene expression has not been previously studied. In our cell
lines, IFN-y mediated Ia-induction was highly cycloheximide-
sensitive, indicating that protein synthesis is necessary to
promote Ia expression in these cells. Ia induction by IFN-y in a
glioblastoma cell line is not cycloheximide-sensitive [48],
whereas such induction in macrophage-like P388D1 cells [44]
and osteosarcoma cells [49] is cycloheximide-sensitive. IFN-y
induced MHC class II gene expression in HeLa cells [46],
glioblastoma cells [48] and class II transfected fibroblasts [471 is
regulated by transcriptional control sequences and nuclear
factors which bind to conserved sequences in the 5' upstream
untranslated region. In P388D1 cells, IFN-y induces DNA-
specific binding proteins which bind to conserved sequences in
the I-E/3 promoter region [45]. It will be of interest to determine
1 2 3 4 5 6
Fig. 7. TNF-a gene expression by Northern analysis in rIL-la and
LPS-siimulated cells (Cl). Lane 1, positive control (MRL-lpr kidney
cortical RNA); lane 2, unstimulated cells; lane 3, rIL-la (Hoffmann-La
Roche, 100 ng/ml, 24 hr); lane 4, rIL-la (Hoffmann-La Roche, 100
ng/ml, 48 hr); lane 5, rIL-la (Pfizer, 100 ng/ml, 48 hr); lane 6, LPS (I
sg/ml, 48 hr).
whether the transcriptional regulation of Ia expression by
IFN-y in tubular epithelial cells is different from that in immune
system cells.
MHC class II molecules are polymorphic cell surface het-
erodimers crucial for foreign antigen presentation to T cells of
the CD4 phenotype [50]. Macrophages and B cells are the
classical antigen presenting cells (APC). We now report, for the
first time, that tubular epithelial cells are capable of MHC-
restricted, foreign protein-specific antigen presentation. Other
non-hematopojetic cells such as thyroid epithelial cells [51, 52],
gut epithelial cells [61 and chondrocytes [5] are able to present
antigen in the context of class II, while other cells such as
keratinocytes are incapable of this function [7]. In another
study [30], PT derived from an interstitial nephritis model can
support the proliferation of a T cell clone specific for the
nephritic antigen produced by these Fr, confirming that PT can
interact with cells of the immune system to promote infiamma-
1 8S —
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tion. On the other hand, cultured human kidney epithelial cells
induce only limited proliferation of allogeneic lymphocytes in a
primary mixed lymphocyte kidney culture when compared with
peripheral blood mononuclear stimulator cells [53]. Although
PT are less efficient APC than B cell lines, their abundance in
the kidney could contribute substantially to antigen presenta-
tion.
Various cells of non-hematopoietic lineage express cytokines
and can influence immune-mediated cellular injury. Endothelial
and vascular smooth muscle cells for example can be induced to
express the cytokines IL-i and TNF [54—56]. Other investiga-
tors demonstrated IL-i production by keratinocytes [57], and
mesangial cells can produce IL-i [58, 59] and TNF [60]. In a
preliminary report, others have also shown an "IL-i like"
bioactivity in supernatants from cultured PT [61]. We investi-
gated whether tubular epithelial cell lines can express cytokines
by measuring mRNA for cytokines. Of the four cytokines
tested, IL-ia, IL-1f3 and IL-6 are not expressed, whereas upon
stimulation with IL-la or LPS, tubular epithelial cells express
TNF-a mRNA. The precise role of TNF expression by tubular
epithelial cells and other non-immunologic cells is largely
unknown. However, TNF has many proinflammatory effects
such as prostaglandin release, collagenase synthesis, cytotox-
icity and macrophage chemoattraction [62]. We have previously
shown increased IL-i and TNF production in the kidneys of
MRL-/pr mice with nephritis [15, 16], suggesting a crucial role
of these cytokines in the pathogenesis of autoimmune renal
injury. We speculate that local release of TNF by PT may have
a pathogenic role in immune renal injury.
In conclusion, transformation of renal cortical tubular cells
resulted in the generation of differentiated PT-like epithelial cell
lines. These cell lines can express Ta antigens when induced
with IFN-y, and Ta expression confers antigen presenting ability
to these cells. Furthermore, these cell lines express TNF-a
when stimulated with IL-i or LPS. These results suggest that in
addition to their physiological role of fluid and solute reabsorp-
tion, PT can participate in immune responses in the kidney.
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